Go Pro
NASDAQ:ODTX

Odyssey Therapeutics Q2 2026 Earnings Report

$26.62 +2.12 (+8.65%)
As of 09/2/2026 04:00 PM Eastern

Odyssey Therapeutics EPS Results

Actual EPS
-$1.74
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Odyssey Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Odyssey Therapeutics Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Tuesday, August 4, 2026
Conference Call Time
7:00AM ET

Odyssey Therapeutics Earnings Headlines

What is HC Wainwright's Estimate for ODTX Q3 Earnings?
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel
Odyssey Therapeutics Inc.
Odyssey Therapeutics: Q2 Earnings Snapshot
See More Odyssey Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Odyssey Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Odyssey Therapeutics and other key companies, straight to your email.

About Odyssey Therapeutics

Odyssey Therapeutics (NASDAQ:ODTX) Inc. is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines which are designed to precisely target disease pathology. Odyssey Therapeutics Inc. is based in BOSTON.

View Odyssey Therapeutics Profile